Brian Gabrielli

7.7k citations

129 papers · 6.0k indexed · h-index 47

Impact in

Cell Biology top 0.5%
- Microtubule and mitosis dynamics
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in

Cell Biology 55
- Microtubule and mitosis dynamics 42
Oncology 62
- Cancer-related Molecular Pathways 37

Co-authors: Sandra Pavey K.A.O. Ellem Alistair R. R. Forrest Andrew Burgess Heather Beamish Peter G. Parsons Nichole Giles Colin P. C. De Souza
Journals: Journal of Biological Chemistry (14 papers)Oncogene (12 papers)Journal of Investigative Dermatology (7 papers)Pigment Cell & Melanoma Research (6 papers)Cell Cycle (5 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Brian Gabrielli

128 papers receiving 5.9k citations

Peers

Countries citing papers authored by Brian Gabrielli

Since Specialization

Citations

This map shows the geographic impact of Brian Gabrielli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gabrielli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gabrielli more than expected).

Fields of papers citing papers by Brian Gabrielli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gabrielli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gabrielli. The network helps show where Brian Gabrielli may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Gabrielli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Gabrielli Line = papers co-authored together Brian Gabrielli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition Cell Death and Disease ·Shivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar, Deborah Nazareth, Alexis Bonfim‐Melo, Yoon Lim, Xin Yee Ong, Madushan Fernando, Yaowu He, John D. Hooper, Nigel A.J. McMillan, Jelena Urosevic, Jon Travers, Jamal Saeh, Sharad Kumar, Mathew V. Jones, Brian Gabrielli	2024	4
2	Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells British Journal of Cancer ·Esha T. Shah, Christopher J. Molloy, Madeline Gough, Thomas Kryza, Selwin Gabriel Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian Gabrielli, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams	2024	8
3	The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence International Journal of Molecular Sciences ·Caroline Atkinson, Aideen McInerney‐Leo, Martina Proctor, Catherine Lanagan, Alexander J. Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J. Maas, Stephen A. Ainger, Antonia L. Pritchard, Peter A. Johansson, Paul Leo, Nicholas K. Hayward, Richard A. Sturm, Emma L. Duncan, Brian Gabrielli	2024	0
4	Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas Pigment Cell & Melanoma Research ·Zhen Zeng, Hung Long Ngo, Martina Proctor, Helen Rizos, Riccardo Dolcetti, Jazmina L. Gonzalez Cruz, James W. Wells, Brian Gabrielli	2023	2
5	Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression Cancers ·Martina Proctor, Jazmina L. Gonzalez Cruz, Sheena M. Daignault-Mill, Margaret Veitch, Bijun Zeng, Anna Ehmann, Muhammed B. Sabdia, Cameron Snell, Colm Keane, Riccardo Dolcetti, Nikolas K. Haass, James W. Wells, Brian Gabrielli	2021	13
6	Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours Oncogenesis ·Madushan Fernando, Pascal H. G. Duijf, Martina Proctor, Alexander J. Stevenson, Anna Ehmann, Shivam Vora, Dubravka Škalamera, Mark N. Adams, Brian Gabrielli	2021	12
7	Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts Journal of Cell Science ·Dubravka Škalamera, Alexander J. Stevenson, Anna Ehmann, Stephen A. Ainger, Catherine Lanagan, Richard A. Sturm, Brian Gabrielli	2019	5
8	Mechanism of action of the third generation benzopyrans and evaluation of their broad anti-cancer activity in vitro and in vivo Scientific Reports ·Alexander J. Stevenson, Eleanor I Ager, Martina Proctor, Dubravka Škalamera, Andrew Heaton, David Brown, Brian Gabrielli	2018	13
9	Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo Clinical Cancer Research ·Zay Yar Oo, Alexander J. Stevenson, Martina Proctor, Sheena M. Daignault, Sebastian Walpole, Catherine Lanagan, James Chen, Dubravka Škalamera, Loredana Spoerri, Stephen A. Ainger, Richard A. Sturm, Nikolas K. Haass, Brian Gabrielli	2018	17
10	Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors Molecular Cancer Therapeutics ·David Martin, Sora Fallaha, Martina Proctor, Alexander J. Stevenson, Lewis Perrin, Nigel A.J. McMillan, Brian Gabrielli	2017	18
11	Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS -Mutant Cancers Clinical Cancer Research ·Heinz Hammerlindl, Dinoop Ravindran Menon, Sabrina Hammerlindl, Abdullah Al Emran, Joachim Torrano, Katrin Sproesser, Divya Thakkar, Min Xiao, Victoria Atkinson, Brian Gabrielli, Nikolas K. Haass, Meenhard Herlyn, Clemens Krepler, Helmut Schaider	2017	15
12	Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells Cell Cycle ·Claire Levrier, Anja Rockstroh, Brian Gabrielli, Maria Kavallaris, Melanie Lehman, Rohan A. Davis, Martin C. Sadowski, Colleen C. Nelson	2017	13
13	6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells Molecular Cancer Therapeutics ·Claire Levrier, Martin C. Sadowski, Anja Rockstroh, Brian Gabrielli, Maria Kavallaris, Melanie Lehman, Rohan A. Davis, Colleen C. Nelson	2016	19
14	Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells Journal of Investigative Dermatology ·Kimberley A. Beaumont, David S. Hill, Sheena M. Daignault, Goldie Y.L. Lui, Danae M. Sharp, Brian Gabrielli, Wolfgang Weninger, Nikolas K. Haass	2016	48
15	Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer Molecular Cancer Therapeutics ·Brian Gabrielli, Fawzi Bokhari, Max V. Ranall, Zay Yar Oo, Alexander J. Stevenson, Weili Wang, Melanie Murrell, Mushfiq Hassan Shaikh, Sora Fallaha, Daniel Clarke, Madison J. Kelly, Karin Sedelies, Melinda E. Christensen, Sara McKee, Graham R. Leggatt, Paul Leo, Dubravka Škalamera, H. Peter Soyer, Thomas J. Gonda, Nigel A.J. McMillan	2015	35
16	CDC25B Overexpression Stabilises Centrin 2 and Promotes the Formation of Excess Centriolar Foci PLoS ONE ·Rose Boutros, Odile Mondesert, Corinne Lorenzo, Puji Astuti, Grant A. McArthur, Megan Chircop, Bernard Ducommun, Brian Gabrielli	2013	23
17	The Histone Deacetylase Inhibitor MGCD0103 Has Both Deacetylase and Microtubule Inhibitory Activity Molecular Pharmacology ·Kee Ming Chia, Heather Beamish, Kaneez Jafferi, Brian Gabrielli	2010	9
18	Cyclin A/cdk2 Regulates Adenomatous Polyposis Coli-dependent Mitotic Spindle Anchoring Journal of Biological Chemistry ·Heather Beamish, Leonore de Boer, Nichole Giles, Frankie Stevens, Vanessa Oakes, Brian Gabrielli	2009	17
19	Spontaneous and UV Radiation–Induced Multiple Metastatic Melanomas in Cdk4R24C/R24C/TPras Mice Cancer Research ·Elke Hacker, H. Konrad Muller, Nicole Irwin, Brian Gabrielli, Douglas Lincoln, Sandra Pavey, Marianne Broome Powell, Marcos Malumbres, Mariano Barbacid, Nicholas K. Hayward, Graeme J. Walker	2006	41
20	Spontaneous and UVR-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice Faculty of Health ·Elke Hacker, H. Konrad Muller, Nicole Irwin, Brian Gabrielli, Doug Lincoln, Sandra Pavey, Marianne Broome-Powell, Marcos Malumbres, Mariano Barbacid, Nicholas K. Hayward, Graeme J. Walker	2006	1

About Brian Gabrielli

Brian Gabrielli is a scholar working on Cell Biology, Oncology, Molecular Biology, Immunology and Cancer Research, having authored 129 papers that have together received 6.0k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (42 papers), Cancer-related Molecular Pathways (37 papers), DNA Repair Mechanisms (20 papers), Histone Deacetylase Inhibitors Research (17 papers), Epigenetics and DNA Methylation (16 papers), Ubiquitin and proteasome pathways (15 papers), Melanoma and MAPK Pathways (14 papers) and Protein Degradation and Inhibitors (11 papers). The work is most often cited by research in Cell Biology (1.6k citations), Oncology (2.1k citations), Molecular Biology (4.6k citations), Cancer Research (887 citations) and Aging (59 citations). Brian Gabrielli has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Sandra Pavey, K.A.O. Ellem, Alistair R. R. Forrest, Andrew Burgess, Heather Beamish, Peter G. Parsons, Nichole Giles, Colin P. C. De Souza, Robyn Warrener and Helen Piwnica‐Worms. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Journal of Investigative Dermatology, Pigment Cell & Melanoma Research and Cell Cycle.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact